VACCINES
Medigen’s vaccines are intended primarily for high-impact emerging pathogens capable of causing global epidemics and pandemics. Our goal is to protect human life with life-long immunity.
The increase in global travel, climate changes, urbanization, and other factors favor expansion of emerging diseases to new areas. We develop safe and effective vaccines that can be used by the first responders and emergency personnel, travelers, and local populations in the affected areas. In addition, our vaccines can be stockpiled for emergency use if the diseases spread to new areas.
Medigen also develops vaccines for chronic conditions such as cancer. Our advantage is the inherent biological safety “by design” and unsurpassed efficacy of our vaccines. Each vaccine is custom-designed for a particular disease in order to ensure safety and effectiveness in all populations.
For more information about Medigen vaccines and technologies, please contact info@medigen-usa.com
Venezuelan equine encephalitis
Venezuelan equine encephalitis (VEE) virus causes outbreaks in the North, Central, and South America and has spread to the southern U.S. in the past, [...]
Chikungunya
Chikungunya virus (CHIKV) causes chikungunya fever, a global infectious disease. The virus is found worldwide including Europe and the U.S. CHIKV is transmitted to [...]
Lassa fever
Lassa fever is a hemorrhagic fever caused by the Lassa virus that commonly spreads to humans in Africa from the rodent Mastomys natalensis. Symptoms [...]
Japanese encephalitis
Japanese encephalitis virus (JEV) is the main cause of viral encephalitis in many countries of Asia with an estimated 68,000 clinical cases every year [...]
Yellow Fever
Yellow fever (YF) causes an acute hemorrhagic fever disease in tropical Africa and Latin America. The YF vaccine YF17D is available and is prepared [...]
Dengue and Zika
Dengue and Zika viruses are mosquito-borne flaviviruses related to Japanese encephalitis and yellow fever viruses. Estimates indicate ~400 million of dengue infections per year, [...]
